PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1 - NCT00829829-28144 (Clinical Trial 265757)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy265757.aspx
|
** Please review additional "Nearby Studies" on right ----->
This is an archived study that is no longer available, if you
would like to find active studies please
search our studies.
|
|
 |
 |
|
| City: |
|
Salisbury |
|
State:
|
|
NC |
| Zip Code: |
|
28144 |
| Conditions: |
|
Intercritical Gout |
| Purpose: |
|
The purpose of this clinical research study is to determine the safety and effectiveness of
an experimental drug called rilonacept in subjects with gout who are beginning allopurinol
treatment for gout. Subjects will participate in this study for approximately 22 weeks.
Rilonacept is being studied for use in preventing allopurinol-induced gout flares.
|
| Study summary: |
|
This study is no longer available. |
| Criteria: |
|
This study is no longer available. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
December 30, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|